Major players in the Market are DENTSPLY International Inc. (U.S.), Wright Medical Group Inc. (U.S.), DePuy Orthopaedics Inc. (U.S.), Invibio Ltd. (U.K.), Osteotech Inc. (U.S.), Biomet Inc. (U.S.), & few more.
(PRWEB) April 10, 2013
The "Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] - Global Forecasts To 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.
- 220 Market Data Tables
- 33 Figures
- 504 Pages and an in-depth Table of Content on “Biomaterials Market"
Early buyers will receive 10% customization on this report.
This report studies the global biomaterials market over the forecast period of 2012-2017. The global market for biomaterials is estimated at $44.0 billion in 2012 and is poised to grow at a CAGR of 15% from 2012 to 2017 to reach $88.4 billion by 2017.
The global market is broadly segmented into two categories, by type and by application.
The global Biomaterials Market by Types is broadly categorized into
- Polymers, and natural biomaterials.
The Applications Market is broadly segmented into
- Tissue Engineering
- Wound Healing
- Plastic Surgery
- Ophthalmology and
- Other Applications such as Gastrointestinal, Urinary, Bariatric Surgery, and Drug Delivery System.
In 2012, the cardiovascular biomaterial segment contributed 34.5% to the global biomaterial market, followed by the orthopedic segment. Plastic surgery and wound healing applications are expected to witness the highest growth in the coming years.
The biomaterial polymers market is expected to show the highest growth at a CAGR of 22.1% (2012-2017) due to tremendous ongoing research for the development of biodegradable and bio-compatible polymeric biomaterial and its use in a wide range of applications.
North America is the largest biomaterials market and is expected to grow at a high CAGR from the year 2012 to 2017 due to an increase in the aging population. Due to rising awareness of biomaterial products in Asia, and increased conferences and collaborations, the Asian market is expected to grow at a CAGR of 21.5% from 2012 to 2017.
The key raw material supplier companies are Carpenter Technology Corporation (U.S.), Materion Corporation (U.S.), Ulbrich Stainless Steel & Special Metals, Inc. (U.S.), Heraeus Medical Components, CeramTec (a subsidiary of Rockwood Holdings Inc.), (Germany), Ceradyne, Inc. (U.S.), Kyocera Corporation (Japan), Bayer (Germany), Purac Biomaterials (Netherlands), DSM Biomedical, Inc. (U.S.), Evonik Industries (Germany), Cam Bioceramics (Netherlands), Ticona GmbH (Germany), and Landec Corporation (U.S.).
Buy a copy of this report @ http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=393
Browse related Reports to - Biotech-Market
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Connect with us on LinkedIn
Connect with us on Facebook